B. B. Fuks

3.2k total citations · 1 hit paper
40 papers, 2.4k citations indexed

About

B. B. Fuks is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Immunology. According to data from OpenAlex, B. B. Fuks has authored 40 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Cellular and Molecular Neuroscience and 11 papers in Immunology. Recurrent topics in B. B. Fuks's work include Neuroscience and Neuropharmacology Research (8 papers), Epilepsy research and treatment (7 papers) and Lipid Membrane Structure and Behavior (5 papers). B. B. Fuks is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Epilepsy research and treatment (7 papers) and Lipid Membrane Structure and Behavior (5 papers). B. B. Fuks collaborates with scholars based in Belgium, Russia and United States. B. B. Fuks's co-authors include Alain Matagne, Nathalie Lambeng, Berkley A. Lynch, Karl Nocka, Sandra Bajjalieh, Patricia Kensel-Hammes, Michel Gillard, Pierre Chatelain, Danny J. Schnell and Fabrice Homblé and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

B. B. Fuks

38 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

2004 1.1k citations Berkley A. Lynch, Nathalie Lambeng et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B. B. Fuks Belgium	16	1.2k	1.1k	933	816	190	40	2.4k
Claudia Brandt Germany	32	1.6k 1.3×	1.7k 1.5×	734 0.8×	879 1.1×	95 0.5×	60	2.8k
Alain Matagne Belgium	26	2.5k 2.1×	2.2k 1.9×	800 0.9×	1.8k 2.1×	28 0.1×	33	3.5k
Arsélio P. Carvalho Portugal	35	255 0.2×	1.4k 1.2×	1.7k 1.8×	214 0.3×	81 0.4×	88	3.2k
Gabriele Micheletti Italy	26	801 0.7×	1.5k 1.3×	959 1.0×	388 0.5×	22 0.1×	111	2.6k
David S. Ragsdale Canada	29	679 0.6×	2.9k 2.6×	3.5k 3.7×	171 0.2×	65 0.3×	42	4.4k
Mark Pierce United States	27	606 0.5×	393 0.3×	895 1.0×	400 0.5×	20 0.1×	51	2.1k
Qian Zhao China	28	445 0.4×	548 0.5×	638 0.7×	265 0.3×	63 0.3×	125	2.1k
Bruce Lippert France	12	279 0.2×	665 0.6×	617 0.7×	144 0.2×	213 1.1×	19	1.5k
Nancy C. Lan United States	28	189 0.2×	1.1k 1.0×	972 1.0×	111 0.1×	44 0.2×	41	2.9k
Manoj K. Patel United States	31	457 0.4×	976 0.9×	1.3k 1.4×	136 0.2×	31 0.2×	86	2.8k

Countries citing papers authored by B. B. Fuks

Since Specialization

Citations

This map shows the geographic impact of B. B. Fuks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. B. Fuks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. B. Fuks more than expected).

Fields of papers citing papers by B. B. Fuks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. B. Fuks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. B. Fuks. The network helps show where B. B. Fuks may publish in the future.

Co-authorship network of co-authors of B. B. Fuks

This figure shows the co-authorship network connecting the top 25 collaborators of B. B. Fuks. A scholar is included among the top collaborators of B. B. Fuks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. B. Fuks. B. B. Fuks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jnoff, Eric, B. Christophe, Philippe Collart, et al.. (2012). Discovery of Selective Alpha_2CAdrenergic Receptor Agonists. ChemMedChem. 7(3). 385–390. 4 indexed citations

Gillard, Michel, et al.. (2011). Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: Relationship to anti-convulsant properties. European Journal of Pharmacology. 664(1-3). 36–44. 188 indexed citations

Lambeng, Nathalie, Mathis Grossmann, Pierre Chatelain, & B. B. Fuks. (2006). Solubilization and immunopurification of rat brain synaptic vesicle protein 2A with maintained binding properties. Neuroscience Letters. 398(1-2). 107–112. 9 indexed citations

Gillard, Michel, Pierre Chatelain, & B. B. Fuks. (2006). Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein. European Journal of Pharmacology. 536(1-2). 102–108. 127 indexed citations

Fuks, B. B., et al.. (2005). In vitro properties of 5-(benzylsulfonyl)-4-bromo-2-methyl-3(2H)-pyridazinone: A novel permeability transition pore inhibitor. European Journal of Pharmacology. 519(1-2). 24–30. 15 indexed citations

Lambeng, Nathalie, Michel Gillard, Pascale Vertongen, B. B. Fuks, & Pierre Chatelain. (2005). Characterization of [3H]ucb 30889 binding to synaptic vesicle protein 2A in the rat spinal cord. European Journal of Pharmacology. 520(1-3). 70–76. 23 indexed citations

Piret, Jean‐Pascal, Thierry Arnould, B. B. Fuks, et al.. (2004). Caspase activation precedes PTP opening in TNF-α-induced apoptosis in L929 cells. Mitochondrion. 3(5). 261–278. 8 indexed citations

Wolff, Christian, B. B. Fuks, & Pierre Chatelain. (2003). Comparative Study of Membrane Potential-Sensitive Fluorescent Probes and their Use in Ion Channel Screening Assays. SLAS DISCOVERY. 8(5). 533–543. 91 indexed citations

Piret, Jean‐Pascal, Thierry Arnould, B. B. Fuks, et al.. (2003). Mitochondria permeability transition-dependent tert-butyl hydroperoxide-induced apoptosis in hepatoma HepG2 cells. Biochemical Pharmacology. 67(4). 611–620. 59 indexed citations

10.

Fuks, B. B., Michel Gillard, Philippe Michel, et al.. (2003). Localization and photoaffinity labelling of the levetiracetam binding site in rat brain and certain cell lines. European Journal of Pharmacology. 478(1). 11–19. 51 indexed citations

11.

Gillard, Michel, B. B. Fuks, Philippe Michel, et al.. (2003). Binding characteristics of [3H]ucb 30889 to levetiracetam binding sites in rat brain. European Journal of Pharmacology. 478(1). 1–9. 57 indexed citations

12.

Bocquet, Arnaud, et al.. (2001). Failure of GPI compounds to display neurotrophic activity in vitro and in vivo. European Journal of Pharmacology. 415(2-3). 173–180. 22 indexed citations

13.

Fuks, B. B. & Fabrice Homblé. (1999). Passive anion transport through the chloroplast inner envelope membrane measured by osmotic swelling of intact chloroplasts. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1416(1-2). 361–369. 11 indexed citations

14.

Fuks, B. B. & Danny J. Schnell. (1997). Mechanism of Protein Transport across the Chloroplast Envelope. PLANT PHYSIOLOGY. 114(2). 405–410. 53 indexed citations

15.

Fuks, B. B. & Fabrice Homblé. (1994). Permeability and electrical properties of planar lipid membranes from thylakoid lipids. Biophysical Journal. 66(5). 1404–1414. 34 indexed citations

16.

Fuks, B. B., et al.. (1987). [Activation of the production of the tumor-necrosis factor by the combined action of lipopolysaccharide and muramyl dipeptide in vitro and in vivo].. PubMed. 104(10). 497–9. 1 indexed citations

17.

Fuks, B. B., et al.. (1986). Investigation of the pharmacokinetics and mechanism of the action ofEleutherococcus glycosides VIII. Investigation of the activation of natural killers byEleutherococcus extract. Pharmaceutical Chemistry Journal. 20(8). 528–531. 1 indexed citations

18.

Fuks, B. B., et al.. (1983). Low activity of natural killers in patients with multiple basal cell carcinoma and gorlins syndrome. Immunologiya. 4. 48–50. 1 indexed citations

19.

Fuks, B. B., et al.. (1967). Cytochemical study of interaction between lymphocytes and target cells in tissue culture. Experimental Cell Research. 48(3). 656–660. 21 indexed citations

20.

Fuks, B. B., et al.. (1960). Activation of lipolytic enzymes in the wall of the human aorta in atherosclerosis.. Proceedings of the USSR Academy of Sciences. 134. 443–444. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact